Insider Trading History of Alta Embarcadero Biopharma Partners Iii Llc

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Alta Embarcadero Biopharma Partners Iii Llc since 2005. The trader's CIK number is 1280238. At the time of the last reporting, Alta Embarcadero Biopharma Partners Iii Llc was the Director of Aegerion Pharmaceuticals, Inc.. (stock ticker symbol AEGR). Also see all insider trading activities at Aegerion Pharmaceuticals, Inc..

Note that in the past ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Aegerion Pharmaceuticals, Inc. (AEGR) by Alta Embarcadero Biopharma Partners Iii Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 AEGR 9,700 $120,703 0 $0 0 $0

Yearly summary of insider trading at Cotherix Inc (CTRX) by Alta Embarcadero Biopharma Partners Iii Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2005 CTRX 0 $0 414,251 $5,385,263 0 $0


Insider trading activities at 2 companies by Alta Embarcadero Biopharma Partners Iii Llc:

1. Aegerion Pharmaceuticals, Inc. (AEGR)

2. Cotherix Inc (CTRX)

Table 1. Insider trading of Aegerion Pharmaceuticals, Inc. (AEGR) by Alta Embarcadero Biopharma Partners Iii Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-08-09 AEGR Buy 5,500 12.45 68,497
2011-08-08 AEGR Buy 4,200 12.43 52,206

Table 2. Insider trading of Cotherix Inc (CTRX) by Alta Embarcadero Biopharma Partners Iii Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2005-10-14 CTRX Sale 166,937 13.00 2,170,181
2005-10-12 CTRX Sale 247,314 13.00 3,215,082

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Alta Embarcadero Biopharma Partners Iii Llc (Director of Aegerion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.